Amendment to Schedule 13D for IceCure Medical Ltd.

This filing is an amendment to a previously filed Schedule 13D by Epoch Partner Investments Limited and Mr. Li Haixiang. The amendment is primarily to report Mr. Li Haixiang's resignation from the board of directors of IceCure Medical Ltd. on March 17, 2026. The Reporting Persons collectively beneficially own 35,846,597 Ordinary Shares, representing approximately 45.8% of the outstanding shares as of December 31, 2025. Epoch Partner Investments Limited is the entity that directly holds these shares, with Mr. Li Haixiang's beneficial ownership stemming from his role as the sole director of Epoch. Neither reporting person has been involved in criminal or significant civil legal proceedings in the past five years. No transactions in the Ordinary Shares were effected by the Reporting Persons in the past 60 days. The principal business address for the Reporting Persons is in Hong Kong.